Schram, A. M., Clay, T. D., Prenen, H., Park, J. J., Lunger, L., Hussain, J., Maier, D., Kitano, S., Dumbrava, E. E., Kim, H., Ponz-Sarvise, M., Guo, Y. (2025). Beamion PANTUMOR-1: A phase II, multicenter, multicohort, open-label trial to evaluate the efficacy and safety of the oral HER2-selective tyrosine kinase inhibitor zongertinib for the treatment of
            <i>HER2</i>
            -mutated or overexpressed/amplified solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps3187